IndraLab

Statements


YOD1 inhibits TRIM33. 3 / 3
| 3

reach
"Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma."

reach
"Conversely, increased YOD1 expression blocks ERK signaling by stabilizing TRIM33 activation, thereby inhibiting tumor invasion and lymph node metastasis in squamous cell carcinoma of the head and neck [25]."

reach
"Inversely, loss of YOD1 decreased TRIM33 obviously (Fig. 4D)."